Global Biosimilars Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
- Report Code : MAI1978566
- Published On: Aug, 2020
- Category : Healthcare & Pharma
- Pages : 116
-
A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA‐approved biologic product, known as a reference product, and has no clinically meaningful differences in terms of safety and effectiveness from the reference product. Only minor differences in clinically inactive components are allowable in biosimilar products.
The Biosimilars market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Biosimilars industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Biosimilars market can be split based on product types, major applications, and important countries as follows:
Key players in the global Biosimilars market covered in Chapter 12:
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche AG
Samsung Bioepis
Mylan N.V
Biocon
Dr. Reddy’s Laboratories Ltd.
Amgen Inc
Pfizer Inc.
Sandoz International GmbH
In Chapter 4 and 14.1, on the basis of types, the Biosimilars market from 2015 to 2025 is primarily split into:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
In Chapter 5 and 14.2, on the basis of applications, the Biosimilars market from 2015 to 2025 covers:
Oncology
Blood Disorders
Growth Hormonal Deficiency
Chronic and Autoimmune Disorders
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
-
With tables and figures helping analyze worldwide Global Biosimilars market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Content
1 Biosimilars Introduction and Market Overview1.1 Objectives of the Study
1.2 Overview of Biosimilars
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Biosimilars industry1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary2.1 Market Overview
2.1.1 Global Biosimilars Market Size, 2015 – 2020
2.1.2 Global Biosimilars Market Size by Type, 2015 – 2020
2.1.3 Global Biosimilars Market Size by Application, 2015 – 2020
2.1.4 Global Biosimilars Market Size by Region, 2015 - 20252.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Biosimilars Industry Development
3 Industry Chain Analysis3.1 Upstream Raw Material Suppliers of Biosimilars Analysis
3.2 Major Players of Biosimilars
3.3 Biosimilars Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Biosimilars
3.3.3 Labor Cost of Biosimilars3.4 Market Distributors of Biosimilars
3.5 Major Downstream Buyers of Biosimilars Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Biosimilars Market, by Type4.1 Global Biosimilars Value and Market Share by Type (2015-2020)
4.2 Global Biosimilars Production and Market Share by Type (2015-2020)
4.3 Global Biosimilars Value and Growth Rate by Type (2015-2020)
4.3.1 Global Biosimilars Value and Growth Rate of Human Growth Hormone
4.3.2 Global Biosimilars Value and Growth Rate of Erythropoietin
4.3.3 Global Biosimilars Value and Growth Rate of Monoclonal Antibodies
4.3.4 Global Biosimilars Value and Growth Rate of Insulin
4.3.5 Global Biosimilars Value and Growth Rate of Interferon
4.3.6 Global Biosimilars Value and Growth Rate of Granulocyte-Colony Stimulating Factor
4.3.7 Global Biosimilars Value and Growth Rate of Others4.4 Global Biosimilars Price Analysis by Type (2015-2020)
5 Biosimilars Market, by Application5.1 Downstream Market Overview
5.2 Global Biosimilars Consumption and Market Share by Application (2015-2020)
5.3 Global Biosimilars Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Biosimilars Consumption and Growth Rate of Oncology (2015-2020)
5.3.2 Global Biosimilars Consumption and Growth Rate of Blood Disorders (2015-2020)
5.3.3 Global Biosimilars Consumption and Growth Rate of Growth Hormonal Deficiency (2015-2020)
5.3.4 Global Biosimilars Consumption and Growth Rate of Chronic and Autoimmune Disorders (2015-2020)
5.3.5 Global Biosimilars Consumption and Growth Rate of Others (2015-2020)
6 Global Biosimilars Market Analysis by Regions6.1 Global Biosimilars Sales, Revenue and Market Share by Regions
6.1.1 Global Biosimilars Sales by Regions (2015-2020)
6.1.2 Global Biosimilars Revenue by Regions (2015-2020)6.2 North America Biosimilars Sales and Growth Rate (2015-2020)
6.3 Europe Biosimilars Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Biosimilars Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Biosimilars Sales and Growth Rate (2015-2020)
6.6 South America Biosimilars Sales and Growth Rate (2015-2020)
7 North America Biosimilars Market Analysis by Countries7.1 The Influence of COVID-19 on North America Market
7.2 North America Biosimilars Sales, Revenue and Market Share by Countries
7.2.1 North America Biosimilars Sales by Countries (2015-2020)
7.2.2 North America Biosimilars Revenue by Countries (2015-2020)7.3 United States Biosimilars Sales and Growth Rate (2015-2020)
7.4 Canada Biosimilars Sales and Growth Rate (2015-2020)
7.5 Mexico Biosimilars Sales and Growth Rate (2015-2020)
8 Europe Biosimilars Market Analysis by Countries8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Biosimilars Sales, Revenue and Market Share by Countries
8.2.1 Europe Biosimilars Sales by Countries (2015-2020)
8.2.2 Europe Biosimilars Revenue by Countries (2015-2020)8.3 Germany Biosimilars Sales and Growth Rate (2015-2020)
8.4 UK Biosimilars Sales and Growth Rate (2015-2020)
8.5 France Biosimilars Sales and Growth Rate (2015-2020)
8.6 Italy Biosimilars Sales and Growth Rate (2015-2020)
8.7 Spain Biosimilars Sales and Growth Rate (2015-2020)
8.8 Russia Biosimilars Sales and Growth Rate (2015-2020)
9 Asia Pacific Biosimilars Market Analysis by Countries9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Biosimilars Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Biosimilars Sales by Countries (2015-2020)
9.2.2 Asia Pacific Biosimilars Revenue by Countries (2015-2020)9.3 China Biosimilars Sales and Growth Rate (2015-2020)
9.4 Japan Biosimilars Sales and Growth Rate (2015-2020)
9.5 South Korea Biosimilars Sales and Growth Rate (2015-2020)
9.6 India Biosimilars Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Biosimilars Sales and Growth Rate (2015-2020)
9.8 Australia Biosimilars Sales and Growth Rate (2015-2020)
10 Middle East and Africa Biosimilars Market Analysis by Countries10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Biosimilars Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Biosimilars Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Biosimilars Revenue by Countries (2015-2020)10.3 Saudi Arabia Biosimilars Sales and Growth Rate (2015-2020)
10.4 UAE Biosimilars Sales and Growth Rate (2015-2020)
10.5 Egypt Biosimilars Sales and Growth Rate (2015-2020)
10.6 Nigeria Biosimilars Sales and Growth Rate (2015-2020)
10.7 South Africa Biosimilars Sales and Growth Rate (2015-2020)
11 South America Biosimilars Market Analysis by Countries11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Biosimilars Sales, Revenue and Market Share by Countries
11.2.1 South America Biosimilars Sales by Countries (2015-2020)
11.2.2 South America Biosimilars Revenue by Countries (2015-2020)11.3 Brazil Biosimilars Sales and Growth Rate (2015-2020)
11.4 Argentina Biosimilars Sales and Growth Rate (2015-2020)
11.5 Columbia Biosimilars Sales and Growth Rate (2015-2020)
11.6 Chile Biosimilars Sales and Growth Rate (2015-2020)
12 Competitive Landscape12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Teva Pharmaceutical Industries Ltd. Basic Information
12.1.2 Biosimilars Product Introduction
12.1.3 Teva Pharmaceutical Industries Ltd. Production, Value, Price, Gross Margin 2015-202012.2 F. Hoffmann-La Roche AG
12.2.1 F. Hoffmann-La Roche AG Basic Information
12.2.2 Biosimilars Product Introduction
12.2.3 F. Hoffmann-La Roche AG Production, Value, Price, Gross Margin 2015-202012.3 Samsung Bioepis
12.3.1 Samsung Bioepis Basic Information
12.3.2 Biosimilars Product Introduction
12.3.3 Samsung Bioepis Production, Value, Price, Gross Margin 2015-202012.4 Mylan N.V
12.4.1 Mylan N.V Basic Information
12.4.2 Biosimilars Product Introduction
12.4.3 Mylan N.V Production, Value, Price, Gross Margin 2015-202012.5 Biocon
12.5.1 Biocon Basic Information
12.5.2 Biosimilars Product Introduction
12.5.3 Biocon Production, Value, Price, Gross Margin 2015-202012.6 Dr. Reddy’s Laboratories Ltd.
12.6.1 Dr. Reddy’s Laboratories Ltd. Basic Information
12.6.2 Biosimilars Product Introduction
12.6.3 Dr. Reddy’s Laboratories Ltd. Production, Value, Price, Gross Margin 2015-2020
12.7 Amgen Inc
12.7.1 Amgen Inc Basic Information
12.7.2 Biosimilars Product Introduction
12.7.3 Amgen Inc Production, Value, Price, Gross Margin 2015-2020
12.8 Pfizer Inc.
12.8.1 Pfizer Inc. Basic Information
12.8.2 Biosimilars Product Introduction
12.8.3 Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
12.9 Sandoz International GmbH
12.9.1 Sandoz International GmbH Basic Information
12.9.2 Biosimilars Product Introduction
12.9.3 Sandoz International GmbH Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Biosimilars Market Forecast14.1 Global Biosimilars Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Human Growth Hormone Market Value and Volume Forecast (2020-2025)
14.1.2 Erythropoietin Market Value and Volume Forecast (2020-2025)
14.1.3 Monoclonal Antibodies Market Value and Volume Forecast (2020-2025)
14.1.4 Insulin Market Value and Volume Forecast (2020-2025)
14.1.5 Interferon Market Value and Volume Forecast (2020-2025)
14.1.6 Granulocyte-Colony Stimulating Factor Market Value and Volume Forecast (2020-2025)
14.1.7 Others Market Value and Volume Forecast (2020-2025)14.2 Global Biosimilars Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Oncology Market Value and Volume Forecast (2020-2025)
14.2.2 Blood Disorders Market Value and Volume Forecast (2020-2025)
14.2.3 Growth Hormonal Deficiency Market Value and Volume Forecast (2020-2025)
14.2.4 Chronic and Autoimmune Disorders Market Value and Volume Forecast (2020-2025)
14.2.5 Others Market Value and Volume Forecast (2020-2025)14.3 Biosimilars Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of Biosimilars
Table Product Specification of Biosimilars
Table Biosimilars Key Market Segments
Table Key Players Biosimilars Covered
Figure Global Biosimilars Market Size, 2015 – 2025
Table Different Types of Biosimilars
Figure Global Biosimilars Value ($) Segment by Type from 2015-2020
Figure Global Biosimilars Market Share by Types in 2019
Table Different Applications of Biosimilars
Figure Global Biosimilars Value ($) Segment by Applications from 2015-2020
Figure Global Biosimilars Market Share by Applications in 2019
Figure Global Biosimilars Market Share by Regions in 2019
Figure North America Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure Europe Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars Production Value ($) and Growth Rate (2015-2020)
Figure South America Biosimilars Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Biosimilars
Table Upstream Raw Material Suppliers of Biosimilars with Contact Information
Table Major Players Headquarters, and Service Area of Biosimilars
Figure Major Players Production Value Market Share of Biosimilars in 2019
Table Major Players Biosimilars Product Types in 2019
Figure Production Process of Biosimilars
Figure Manufacturing Cost Structure of Biosimilars
Figure Channel Status of Biosimilars
Table Major Distributors of Biosimilars with Contact Information
Table Major Downstream Buyers of Biosimilars with Contact Information
Table Global Biosimilars Value ($) by Type (2015-2020)
Table Global Biosimilars Value Share by Type (2015-2020)
Figure Global Biosimilars Value Share by Type (2015-2020)
Table Global Biosimilars Production by Type (2015-2020)
Table Global Biosimilars Production Share by Type (2015-2020)
Figure Global Biosimilars Production Share by Type (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Human Growth Hormone (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Erythropoietin (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Monoclonal Antibodies (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Insulin (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Interferon (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Granulocyte-Colony Stimulating Factor (2015-2020)
Figure Global Biosimilars Value ($) and Growth Rate of Others (2015-2020)
Figure Global Biosimilars Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Biosimilars Consumption by Application (2015-2020)
Table Global Biosimilars Consumption Market Share by Application (2015-2020)
Figure Global Biosimilars Consumption Market Share by Application (2015-2020)
Figure Global Biosimilars Consumption and Growth Rate of Oncology (2015-2020)
Figure Global Biosimilars Consumption and Growth Rate of Blood Disorders (2015-2020)
Figure Global Biosimilars Consumption and Growth Rate of Growth Hormonal Deficiency (2015-2020)
Figure Global Biosimilars Consumption and Growth Rate of Chronic and Autoimmune Disorders (2015-2020)
Figure Global Biosimilars Consumption and Growth Rate of Others (2015-2020)
Figure Global Biosimilars Sales and Growth Rate (2015-2020)
Figure Global Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Global Biosimilars Sales by Regions (2015-2020)
Table Global Biosimilars Sales Market Share by Regions (2015-2020)
Table Global Biosimilars Revenue (M USD) by Regions (2015-2020)
Table Global Biosimilars Revenue Market Share by Regions (2015-2020)
Table Global Biosimilars Revenue Market Share by Regions in 2015
Table Global Biosimilars Revenue Market Share by Regions in 2019
Figure North America Biosimilars Sales and Growth Rate (2015-2020)
Figure Europe Biosimilars Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Biosimilars Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Biosimilars Sales and Growth Rate (2015-2020)
Figure South America Biosimilars Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Biosimilars Revenue (M USD) and Growth (2015-2020)
Table North America Biosimilars Sales by Countries (2015-2020)
Table North America Biosimilars Sales Market Share by Countries (2015-2020)
Table North America Biosimilars Revenue (M USD) by Countries (2015-2020)
Table North America Biosimilars Revenue Market Share by Countries (2015-2020)
Figure United States Biosimilars Sales and Growth Rate (2015-2020)
Figure Canada Biosimilars Sales and Growth Rate (2015-2020)
Figure Mexico Biosimilars Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Europe Biosimilars Sales by Countries (2015-2020)
Table Europe Biosimilars Sales Market Share by Countries (2015-2020)
Table Europe Biosimilars Revenue (M USD) by Countries (2015-2020)
Table Europe Biosimilars Revenue Market Share by Countries (2015-2020)
Figure Germany Biosimilars Sales and Growth Rate (2015-2020)
Figure UK Biosimilars Sales and Growth Rate (2015-2020)
Figure France Biosimilars Sales and Growth (2015-2020)
Figure Italy Biosimilars Sales and Growth (2015-2020)
Figure Spain Biosimilars Sales and Growth (2015-2020)
Figure Russia Biosimilars Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Biosimilars Sales by Countries (2015-2020)
Table Asia Pacific Biosimilars Sales Market Share by Countries (2015-2020)
Table Asia Pacific Biosimilars Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Biosimilars Revenue Market Share by Countries (2015-2020)
Figure China Biosimilars Sales and Growth Rate (2015-2020)
Figure Japan Biosimilars Sales and Growth Rate (2015-2020)
Figure South Korea Biosimilars Sales and Growth (2015-2020)
Figure India Biosimilars Sales and Growth (2015-2020)
Figure Southeast Asia Biosimilars Sales and Growth (2015-2020)
Figure Australia Biosimilars Sales and Growth (2015-2020)
Figure Middle East Biosimilars Revenue (M USD) and Growth (2015-2020)
Table Middle East Biosimilars Sales by Countries (2015-2020)
Table Middle East and Africa Biosimilars Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Biosimilars Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Biosimilars Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Biosimilars Sales and Growth Rate (2015-2020)
Figure UAE Biosimilars Sales and Growth Rate (2015-2020)
Figure Egypt Biosimilars Sales and Growth (2015-2020)
Figure Nigeria Biosimilars Sales and Growth (2015-2020)
Figure South Africa Biosimilars Sales and Growth (2015-2020)
Figure South America Biosimilars Revenue (M USD) and Growth (2015-2020)
Table South America Biosimilars Sales by Countries (2015-2020)
Table South America Biosimilars Sales Market Share by Countries (2015-2020)
Table South America Biosimilars Revenue (M USD) by Countries (2015-2020)
Table South America Biosimilars Revenue Market Share by Countries (2015-2020)
Figure Brazil Biosimilars Sales and Growth Rate (2015-2020)
Figure Argentina Biosimilars Sales and Growth Rate (2015-2020)
Figure Columbia Biosimilars Sales and Growth (2015-2020)
Figure Chile Biosimilars Sales and Growth (2015-2020)
Figure Top 3 Market Share of Biosimilars Companies in 2019
Figure Top 6 Market Share of Biosimilars Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table Teva Pharmaceutical Industries Ltd. Profile
Table Teva Pharmaceutical Industries Ltd. Product Introduction
Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Product Introduction
Figure F. Hoffmann-La Roche AG Production and Growth Rate
Figure F. Hoffmann-La Roche AG Value ($) Market Share 2015-2020
Table Samsung Bioepis Profile
Table Samsung Bioepis Product Introduction
Figure Samsung Bioepis Production and Growth Rate
Figure Samsung Bioepis Value ($) Market Share 2015-2020
Table Mylan N.V Profile
Table Mylan N.V Product Introduction
Figure Mylan N.V Production and Growth Rate
Figure Mylan N.V Value ($) Market Share 2015-2020
Table Biocon Profile
Table Biocon Product Introduction
Figure Biocon Production and Growth Rate
Figure Biocon Value ($) Market Share 2015-2020
Table Dr. Reddy’s Laboratories Ltd. Profile
Table Dr. Reddy’s Laboratories Ltd. Product Introduction
Figure Dr. Reddy’s Laboratories Ltd. Production and Growth Rate
Figure Dr. Reddy’s Laboratories Ltd. Value ($) Market Share 2015-2020
Table Amgen Inc Profile
Table Amgen Inc Product Introduction
Figure Amgen Inc Production and Growth Rate
Figure Amgen Inc Value ($) Market Share 2015-2020
Table Pfizer Inc. Profile
Table Pfizer Inc. Product Introduction
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Sandoz International GmbH Profile
Table Sandoz International GmbH Product Introduction
Figure Sandoz International GmbH Production and Growth Rate
Figure Sandoz International GmbH Value ($) Market Share 2015-2020
Table Market Driving Factors of Biosimilars
Table Merger, Acquisition and New Investment
Table Global Biosimilars Market Value ($) Forecast, by Type
Table Global Biosimilars Market Volume Forecast, by Type
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Human Growth Hormone (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Human Growth Hormone (2020-2025)
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Erythropoietin (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Erythropoietin (2020-2025)
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Monoclonal Antibodies (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Monoclonal Antibodies (2020-2025)
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Insulin (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Insulin (2020-2025)
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Interferon (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Interferon (2020-2025)
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Granulocyte-Colony Stimulating Factor (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Granulocyte-Colony Stimulating Factor (2020-2025)
Figure Global Biosimilars Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Biosimilars Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Volume and Growth Rate Forecast of Oncology (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Blood Disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Market Volume and Growth Rate Forecast of Growth Hormonal Deficiency (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Market Volume and Growth Rate Forecast of Chronic and Autoimmune Disorders (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Market Volume and Growth Rate Forecast of Others (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
-
The Global Biosimilars Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Companies in the Global Biosimilars Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
Depending upon the type of applications, the Global Biosimilars Market has been segmented into
The Global Biosimilars Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Global Biosimilars Market as well as its distribution among its players
Companies in the Global Biosimilars Industry are thoroughly researched and profiled in order to determine why certain trends will have a significant impact and how they will be factored into the Global Biosimilars Market's trajectory and future outlook.
